ReviewHeliyon2024
IL-22: A key inflammatory mediator as a biomarker and potential therapeutic target for lung cancer.
Ling Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewHeliyon2024
Ling Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.